Impact of mast cells on the skin

International Journal of Immunopathology and Pharmacology

Volumn 26, Issue 4, 2013, Pages 855-859

  Kritas, Spyridon K ^a   Saggini, A ^b   Varvara, G ^c   Murmura, G ^c   Caraffa, A ^d   Antinolfi, P ^d   Toniato, E ^c   Pantalone, A ^c   Neri, G ^c   Frydas, S ^a   Rosati, M ^e   Tei, M ^f   Speziali, A ^g   Saggini, R ^c   Pandolfi, F ^g   Cerulli, G ^f   Theoharides, T C ^h   Conti, P ^c  

^a ARISTOTLE UNIVERSITY OF THESSALONIKI   (Greece)

^b UNIVERSITY OF ROME TOR VERGATA   (Italy)

^c UNIVERSITY OF CHIETI   (Italy)

^d UNIVERSITY OF PERUGIA   (Italy)

^e Pescara Hospital   (Italy)

^f Nicola's Foundation   (Italy)

^g CATHOLIC UNIVERSITY   (Italy)

^h TUFTS UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Cytokine; Immunity; Inflammation; Mast cells; Skin

Indexed keywords

ANTIGEN PRESENTING CELL; ATOPIC DERMATITIS; CELL ACTIVATION; DERMIS; EPIDERMIS; HUMAN; IMMEDIATE TYPE HYPERSENSITIVITY; IMMUNE RESPONSE; KERATINOCYTE; LANGERHANS CELL; LYMPHOCYTE; MACROPHAGE; MAST CELL; MELANOCYTE; NONHUMAN; PRIORITY JOURNAL; REVIEW; SKIN; T LYMPHOCYTE; ADAPTIVE IMMUNITY; ANTIGEN BINDING; BASOPHIL; BLOOD VESSEL PERMEABILITY; BONE MARROW DERIVED MAST CELL; BRONCHOCONSTRICTION; CELL ADHESION; CELL MATURATION; CELL MIGRATION; CELL PROLIFERATION; CELL STIMULATION; CELLULAR DISTRIBUTION; CELLULAR IMMUNITY; CHRONIC URTICARIA; CYTOKINE PRODUCTION; DENDRITIC CELL; DERMATITIS; ENZYME ACTIVATION; EOSINOPHIL; GENETIC TRANSCRIPTION; HISTAMINE BLOOD LEVEL; IMMUNOGLOBULIN BLOOD LEVEL; INNATE IMMUNITY; INSECT STING; LIPOGENESIS; LYMPHOCYTIC INFILTRATION; NEUTROPHIL; PATHOGENESIS; PATHOPHYSIOLOGY; PROTEIN CROSS LINKING; PROTEIN EXPRESSION; PROTEIN SECRETION; PROTEIN SYNTHESIS; PSORIASIS; SKIN ALLERGY; SKIN LEISHMANIASIS; TH2 CELL; UPREGULATION; VASODILATATION;

COMPLEMENT COMPONENT C3A; COMPLEMENT COMPONENT C4A; COMPLEMENT COMPONENT C5A; ENDOTHELIAL LEUKOCYTE ADHESION MOLECULE 1; FC EPSILON RECEPTOR I; FC RECEPTOR; GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; HISTAMINE; IMMUNOGLOBULIN E; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERLEUKIN 1; INTERLEUKIN 12; INTERLEUKIN 13; INTERLEUKIN 23; INTERLEUKIN 27; INTERLEUKIN 3; INTERLEUKIN 33; INTERLEUKIN 4; INTERLEUKIN 5; INTERLEUKIN 6; LEUKOTRIENE C4; LEUKOTRIENE D4; LEUKOTRIENE E4; MACROPHAGE INFLAMMATORY PROTEIN 1ALPHA; MACROPHAGE INFLAMMATORY PROTEIN 1BETA; PROSTAGLANDIN D2; SLOW REACTING SUBSTANCE; THROMBOCYTE ACTIVATING FACTOR; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG; VASCULOTROPIN;

ANIMALS; DERMATITIS, ATOPIC; HUMANS; INTERLEUKINS; MAST CELLS; SKIN; VASCULAR ENDOTHELIAL GROWTH FACTOR A;

EID: 84893204710     PISSN: 03946320     EISSN: None     Source Type: Journal    
DOI: 10.1177/039463201302600403     Document Type: Review

References (27)

1. Marshall JS, Bienenstock J. The role of mast cells in inflammatory reactions of the airways, skin and intestine. Curr Opin Immunol 1994; 6(6):853-9.
2. White MV. The role of histamine in allergic diseases. J Allergy Clin Immunol 1990; 86(42):599-605.
3. Mori A, Nakayama K, Suzuki J, Nikaido T, Isobe M, Fujii S. Analysis of stem cell factor for mast cell proliferation in the human myometrium. Mol Hum Reprod 1997; 3(5):411-8.
4. Kritas SK, Saggini A, Varvara G, et al. Mast cell involvement in rheumatoid arthritis. J Biol Regul Homeost Agents 2013; 27(3):655-60.
5. Nicoletti M, Neri G, Maccauro G, et al. Impact of neuropeptide substance P an inflammatory compound on arachidonic acid compound generation. Int J Immunopathol Pharmacol 2012; 25(4):849-57.
6. Sobiesiak M, Shumilina E, Lam RS, et al. Impaired mast cell activation in gene-targeted mice lacking the serum- and glucocorticoid-inducible kinase SGK1. J Immunol 2009; 183(7):4395-402.
7. Hylkema MN, Hoekstra MO, Luinge M, Timens W. The strength of the OVA-induced airway inflammation in rats is strain dependent. Clin Exp Immunol 2002; 129(3):390-96.
8. Gonzalez S, Moran M, Kochevar IE. Chronic photodamage in skin of mast cell-deficient mice. Photochem Photobiol 1999; 70(2):248-53.
9. Lorentz A, Schwengberg S, Sellge G, Manns MP, Bischoff SC. Human intestinal mast cells are capable of producing different cytokine profiles: role of IgE receptor cross-linking and IL-4. J Immunol 2000; 164(1):43-8.
10. Maccauro G, Tetè S, Saggini A, et al Induction of CCL2 (MCP-1) by IL-33 in human umbelical cord blood mast cells. Eur J Inflamm 2012; 10:217-26.
11. Bray MA. Leukotriene B4: an inflammatory mediator with vascular actions in vivo. Agents Actions Suppl 1982; 11:51-61.
12. Reck M, Gutzmer R.Management of the cutaneous side effects of therapeutic epidermal growth factor receptor inhibition. Onkologie 2010; 33(8-9):470-9.
13. Ohta R, Torii Y, Imai M, Kimura H, Okada N, Ito Y. Serum concentrations of complement anaphylatoxins and proinflammatory mediators in patients with 2009 H1N1 influenza. Clin Immunol 2011; 55(3):191-8.
14. Askenase PW, Tsuji RF. B-1 B cell IgM antibody initiates T cell elicitation of contact sensitivity. Curr Top Clin Immunol 2000; 252:171-77.
15. Wakashin H, Hirose K, Iwamoto I, Nakajima H. Role of IL-23-Th17 cell axis in allergic airway inflammation. Int Arch Allergy Immunol 2009; 149(S)1:108-12.
16. Egawa M, Mukai K, Yoshikawa S, Iki M, Mukaida N, Kawano Y, Minegishi Y, Karasuyama H. Inflammatory monocytes recruited to allergic skin acquire an anti-inflammatory M2 phenotype via basophil-derived interleukin-4. Immunity 2013; 38(3):570-80.
17. Kautz-Neu K, Schwonberg K, Fischer MR, Schermann AI, von Stebut E. Dendritic cells in Leishmania major infections: mechanisms of parasite uptake, cell activation and evidence for physiological relevance. Med Clin Immunol 2012; 201(4):581-92.
18. Theoharides TC, Singh LK, Boucher W, Pang X, Letourneau R, Webster E, Chrousos G. Corticotropin-releasing hormone induces skin mast cell degranulation and increased vascular permeability, a possible explanation for its proinflammatory effects. Endocrinology 1998; 139(1):403-13.
19. Li YY, Zollner TM, Schon MP. Targeting leukocyte recruitment in the treatment of psoriasis. Clin Dermatol 2008; 26(5):527-38.
20. Komai-Koma M, Brombacher F, Pushparaj PN, et al.Interleukin-33 amplifies IgE synthesis and triggers mast cell degranulation via interleukin-4 in naïve mice. Allergy 2012; 67(9): 1118-26.
21. Kempuraj D, Tagen M, Iliopoulou BP, et al. Luteolin inhibits myelin basic protein-induced human mast cell activation and mast cell-dependent stimulation of Jurkat T cells. Br J Pharmacol 2008; 155(7): 1076-84.
22. Zhang B, Asadi S, Weng Z, Sismanopoulos N, Theoharides TC. Stimulated human mast cells secrete mitochondrial components that have autocrine and paracrine inflammatory actions. PLoS One 2012; 7(12):e49767.
23. Textor B, Licht AH, Tuckermann JP, et al. JunB is required for IgE-mediated degranulation and cytokine release of mast cells. J Immunol 2007; 179(10):6873-80.
24. Kempuraj D, Asadi S, Zhang B, Manola A, Hogan J, Peterson E, Theoharides TC. Mercury induces inflammatory mediator release from human mast cells. J Neuroinflammation 2010; 7:20.
25. Alysandratos KD, Asadi S, Angelidou A, Zhang B, et al. Neurotensin and CRH interactions augment human mast cell activation. PLoS One 2012; 7(11):e48934.
26. Balato A, Lembo S, Mattii M, Schiattarella M, Marino R, De Paulis A, Balato N, Ayala F. IL-33 is secreted by psoriatic keratinocytes and induces pro-inflammatory cytokines via keratinocyte and mast cell activation. Exp Dermatol 2012; 21(11):892-94.
27. Imai Y, Yasuda K, Sakaguchi Y, et al. Skin-specific expression of IL-33 activates group 2 innate lymphoid cells and elicits atopic dermatitis-like inflammation in mice. Proc Natl Acad Sci U S A 2013; 110(34): 13921-26.